CoChat

Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52

Open access
Zgajnar, Nadia, De Leo, Sonia, Lotufo, Cecilia, Erlejman, Alejandra, Piwien-Pilipuk, Graciela, Galigniana, Mario · 2019 · Biomolecules
Cited by 94

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Immunophilins are a family of proteins whose signature domain is the peptidylprolyl-isomerase domain. High molecular weight immunophilins are characterized by the additional presence of tetratricopeptide-repeats (TPR) through which they bind to the 90-kDa heat-shock protein (Hsp90), and via this chaperone, immunophilins contribute to the regulation of the biological functions of several client-proteins. Among these Hsp90-binding immunophilins, there are two highly homologous members named FKBP51 and FKBP52 (FK506-binding protein of 51-kDa and 52-kDa, respectively) that were first characterized as components of the Hsp90-based heterocomplex associated to steroid receptors. Afterwards, they emerged as likely contributors to a variety of other hormone-dependent diseases, stress-related pathologies, psychiatric disorders, cancer, and other syndromes characterized by misfolded proteins. The differential biological actions of these immunophilins have been assigned to the structurally similar, but functionally divergent enzymatic domain. Nonetheless, they also require the complementary input of the TPR domain, most likely due to their dependence with the association to Hsp90 as a functional unit. FKBP51 and FKBP52 regulate a variety of biological processes such as steroid receptor action, transcriptional activity, protein conformation, protein trafficking, cell differentiation, apoptosis, cancer progression, telomerase activity, cytoskeleton architecture, etc. In this article we discuss the biology of these events and some mechanistic aspects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biom9020052

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Research works printed but not linked: 168

  1. 2015, Multidomain Peptidyl Prolyl cis/trans Isomerases, Biochim. Biophys. Acta, 1850, 2005, 10.1016/j.bbagen.2014.11.012 · DOI
  2. Kang, 2008, FKBP family proteins: Immunophilins with versatile biological functions, Neurosignals, 16, 318, 10.1159/000123041 · DOI · Paper page
  3. Kino, 1987, FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro, J. Antibiot., 40, 1256, 10.7164/antibiotics.40.1256 · DOI · Paper page
  4. Kino, 1987, FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics, J. Antibiot., 40, 1249, 10.7164/antibiotics.40.1249 · DOI · Paper page
  5. Ruegger, 1976, [Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity], Helv. Chim. Acta, 59, 1075, 10.1002/hlca.19760590412 · DOI · Paper page
  6. John Wiley & Sons (2005). Ciclosporin. Drug Discovery—A History, John Wiley & Sons.
  7. Hanes, 2015, Prolyl isomerases in gene transcription, Biochim. Biophys. Acta, 1850, 2017, 10.1016/j.bbagen.2014.10.028 · DOI
  8. Matena, 2018, Structure and function of the human parvulins Pin1 and Par14/17, Biol. Chem., 399, 101, 10.1515/hsz-2017-0137 · DOI
  9. Barik, S. (2018). Dual-Family Peptidylprolyl Isomerases (Immunophilins) of Select Monocellular Organisms. Biomolecules. · doi:10.20944/preprints201810.0616.v1
  10. Netzer, 1997, Recombination of protein domains facilitated by co-translational folding in eukaryotes, Nature, 388, 343, 10.1038/41024 · DOI · Paper page
  11. Helbig, 2011, Activation of colicin M by the FkpA prolyl cis-trans isomerase/chaperone, J. Biol. Chem., 286, 6280, 10.1074/jbc.M110.165274 · DOI
  12. Theuerkorn, 2011, Prolyl cis/trans isomerase signalling pathways in cancer, Curr. Opin. Pharmacol., 11, 281, 10.1016/j.coph.2011.03.007 · DOI
  13. Li, 2009, Potentiation by WIN 55,212-2 of GABA-activated currents in rat trigeminal ganglion neurones, Br. J. Pharmacol., 158, 1904, 10.1111/j.1476-5381.2009.00482.x · DOI
  14. Li, 2011, Interaction of calcineurin with substrates and targeting proteins, Trends Cell Biol., 21, 91, 10.1016/j.tcb.2010.09.011 · DOI · Paper page
  15. Callebaut, 1992, An immunophilin that binds M(r) 90,000 heat shock protein: Main structural features of a mammalian p59 protein, Proc. Natl. Acad. Sci. USA, 89, 6270, 10.1073/pnas.89.14.6270 · DOI · Paper page
  16. Smith, 2004, Tetratricopeptide repeat cochaperones in steroid receptor complexes, Cell Stress Chaperones, 9, 109, 10.1379/CSC-31.1 · DOI
  17. Riggs, 2004, Functional specificity of co-chaperone interactions with Hsp90 client proteins, Crit. Rev. Biochem. Mol. Biol., 39, 279, 10.1080/10409230490892513 · DOI · Paper page
  18. Fries, G.R., Gassen, N.C., and Rein, T. (2017). The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease. Int. J. Mol. Sci., 18. · DOI · Paper page
  19. Galigniana, 2018, Structural characteristics of the TPR protein-Hsp90 interaction: A new target in biotechnology, Role of Molecular Chaperones in Structural Folding, Biological Actions, and Drug Interactions of Client Proteins, Volume 1, 73
  20. LeMaster, 2015, Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins, J. Biol. Chem., 290, 15746, 10.1074/jbc.M115.650655 · DOI
  21. Guy, 2015, Functions of the Hsp90-binding FKBP immunophilins, Subcell. Biochem., 78, 35, 10.1007/978-3-319-11731-7_2 · DOI · Paper page
  22. Mazaira, 2018, Gene expression regulation by heat-shock proteins: The cardinal roles of HSF1 and Hsp90, Biochem. Soc. Trans., 46, 51, 10.1042/BST20170335 · DOI
  23. Pratt, 1997, The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase, Annu. Rev. Pharm. Toxicol., 37, 297, 10.1146/annurev.pharmtox.37.1.297 · DOI · Paper page
  24. Mazaira, 2018, The Nuclear Receptor Field: A Historical Overview and Future Challenges, Nucl. Recept. Res., 5, 101320, 10.11131/2018/101320 · DOI
  25. Auricchio, 1989, Phosphorylation of steroid receptors, J. Steroid Biochem., 32, 613, 10.1016/0022-4731(89)90397-X · DOI
  26. Galigniana, 1998, Native rat kidney mineralocorticoid receptor is a phosphoprotein whose transformation to a DNA-binding form is induced by phosphatases, Biochem. J., 333, 555, 10.1042/bj3330555 · DOI · Paper page
  27. McGuinness, 2016, Posttranslational Modifications of Steroid Receptors: Phosphorylation, Methods Mol. Biol., 1443, 105, 10.1007/978-1-4939-3724-0_7 · DOI
  28. Harrell, 2002, All of the protein interactions that link steroid receptor.hsp90.immunophilin heterocomplexes to cytoplasmic dynein are common to plant and animal cells, Biochemistry, 41, 5581, 10.1021/bi020073q · DOI · Paper page
  29. Pratt, 2001, Hsp90-binding immunophilins in plants: The protein movers, Trends Plant Sci., 6, 54, 10.1016/S1360-1385(00)01843-4 · DOI
  30. Erlejman, 2014, Regulatory role of the 90-kDa-heat-shock protein (Hsp90) and associated factors on gene expression, Biochim. Biophys. Acta, 1839, 71, 10.1016/j.bbagrm.2013.12.006 · DOI
  31. Darshan, 2011, Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer, Cancer Res., 71, 6019, 10.1158/0008-5472.CAN-11-1417 · DOI · Paper page
  32. Yang, 1997, Subnuclear trafficking of glucocorticoid receptors in vitro: Chromatin recycling and nuclear export, J. Cell Biol., 137, 523, 10.1083/jcb.137.3.523 · DOI · Paper page
  33. Fu, X., Liang, C., Li, F., Wang, L., Wu, X., Lu, A., Xiao, G., and Zhang, G. (2018). The Rules and Functions of Nucleocytoplasmic Shuttling Proteins. Int. J. Mol. Sci., 19. · DOI
  34. Mazaira, 2014, The Emerging Role of TPR-Domain Immunophilins in the Mechanism of Action of Steroid Receptors, Nucl. Recept. Res., 1, 1, 10.11131/2014/101094 · DOI
  35. Presman, D.M., Alvarez, L.D., Levi, V., Eduardo, S., Digman, M.A., Marti, M.A., Veleiro, A.S., Burton, G., and Pecci, A. (2010). Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids. PLoS ONE, 5. · DOI
  36. Grossmann, 2012, Nuclear shuttling precedes dimerization in mineralocorticoid receptor signaling, Chem. Biol., 19, 742, 10.1016/j.chembiol.2012.04.014 · DOI
  37. Silverstein, 1997, Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilin, J. Biol. Chem., 272, 16224, 10.1074/jbc.272.26.16224 · DOI · Paper page
  38. Madan, 1993, Bidirectional transport of glucocorticoid receptors across the nuclear envelope, Proc. Natl. Acad. Sci. USA, 90, 3588, 10.1073/pnas.90.8.3588 · DOI · Paper page
  39. Galigniana, 2012, Steroid receptor coupling becomes nuclear, Chem. Biol., 19, 662, 10.1016/j.chembiol.2012.06.001 · DOI
  40. Gallo, 2007, Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorticoid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity, Biochemistry, 46, 14044, 10.1021/bi701372c · DOI · Paper page
  41. Erlejman, 2014, Molecular chaperone activity and biological regulatory actions of the TPR-domain immunophilins FKBP51 and FKBP52, Curr. Protein Pept. Sci., 15, 205, 10.2174/1389203715666140331113753 · DOI
  42. Ratajczak, 2015, Steroid Receptor-Associated Immunophilins: A Gateway to Steroid Signalling, Clin. Biochem. Rev., 36, 31
  43. Oroz, 2018, Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex, Nat. Commun., 9, 4532, 10.1038/s41467-018-06880-0 · DOI · Paper page
  44. Echeverria, 2010, Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility, Biochim. Biophys. Acta, 1803, 641, 10.1016/j.bbamcr.2009.11.012 · DOI · Paper page
  45. Ebong, 2016, The interchange of immunophilins leads to parallel pathways and different intermediates in the assembly of Hsp90 glucocorticoid receptor complexes, Cell Discov., 2, 16002, 10.1038/celldisc.2016.2 · DOI · Paper page
  46. Vandevyver, 2012, On the trail of the glucocorticoid receptor: Into the nucleus and back, Traffic, 13, 364, 10.1111/j.1600-0854.2011.01288.x · DOI · Paper page
  47. Jeong, 2016, Hsp90-binding immunophilin FKBP52 modulates telomerase activity by promoting the cytoplasmic retrotransport of hTERT, Biochem. J., 473, 3517, 10.1042/BCJ20160344 · DOI
  48. Vafopoulou, 2012, Cytoplasmic travels of the ecdysteroid receptor in target cells: Pathways for both genomic and non-genomic actions, Front. Endocrinol., 3, 43, 10.3389/fendo.2012.00043 · DOI
  49. Schuster, 2017, The Hsp90 machinery facilitates the transport of diphtheria toxin into human cells, Sci. Rep., 7, 613, 10.1038/s41598-017-00780-x · DOI
  50. Erlejman, 2014, NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: A role for peptidyl-prolyl isomerase activity, J. Biol. Chem., 289, 26263, 10.1074/jbc.M114.582882 · DOI · Paper page
  51. Colo, 2008, The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action, Oncogene, 27, 2430, 10.1038/sj.onc.1210900 · DOI
  52. Lagadari, 2016, Hsp90-binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity, Mol. Oncol., 10, 1086, 10.1016/j.molonc.2016.05.002 · DOI
  53. McKeen, 2008, A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling, Endocrinology, 149, 5724, 10.1210/en.2008-0168 · DOI · Paper page
  54. Nair, 1997, Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor, Mol. Cell. Biol., 17, 594, 10.1128/MCB.17.2.594 · DOI · Paper page
  55. Ratajczak, 1990, Isolation of untransformed bovine estrogen receptor without molybdate stabilization, J. Steroid Biochem., 35, 543, 10.1016/0022-4731(90)90197-Z · DOI
  56. Portella, 2014, Androgen receptor splice variants determine taxane sensitivity in prostate cancer, Cancer Res., 74, 2270, 10.1158/0008-5472.CAN-13-2876 · DOI · Paper page
  57. Pratt, 1993, The hsp56 immunophilin component of steroid receptor heterocomplexes: Could this be the elusive nuclear localization signal-binding protein?, J. Steroid Biochem. Mol. Biol., 46, 269, 10.1016/0960-0760(93)90216-J · DOI
  58. Jhaveri, 2014, Heat shock protein 90 inhibitors in the treatment of cancer: Current status and future directions, Expert Opin. Investig. Drugs, 23, 611, 10.1517/13543784.2014.902442 · DOI · Paper page
  59. Chatterjee, S., and Burns, T.F. (2017). Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach. Int. J. Mol. Sci., 18. · DOI · Paper page
  60. Inda, 2016, Stressing Out Hsp90 in Neurotoxic Proteinopathies, Curr. Top. Med. Chem., 16, 2829, 10.2174/1568026616666160413141350 · DOI
  61. Denny, 2000, Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding, Endocrinology, 141, 4107, 10.1210/endo.141.11.7785 · doi:10.1210/endo.141.11.7785 · Paper page
  62. Ward, 1999, Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer, Breast Cancer Res. Treat., 58, 267, 10.1023/A:1006390804515 · DOI
  63. Ratajczak, 2015, Steroid Receptor-Associated Immunophilins: Candidates for Diverse Drug-Targeting Approaches in Disease, Curr. Mol. Pharmacol., 9, 66, 10.2174/1874467208666150519113639 · DOI
  64. Gougelet, 2005, Estrogen receptor α and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells, J. Steroid Biochem. Mol. Biol., 94, 71, 10.1016/j.jsbmb.2005.01.018 · DOI
  65. Wu, 2016, The environmental endocrine disruptor p-nitrophenol interacts with FKBP51, a positive regulator of androgen receptor and inhibits androgen receptor signaling in human cells, J. Hazard. Mater., 307, 193, 10.1016/j.jhazmat.2015.12.045 · DOI
  66. Joshi, 2017, Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52, Mol. Oncol., 11, 337, 10.1002/1878-0261.12028 · DOI
  67. Sahu, 2013, FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells, Cancer Res., 73, 1570, 10.1158/0008-5472.CAN-12-2350 · DOI · Paper page
  68. Yemelyanov, 2007, Tumor suppressor activity of glucocorticoid receptor in the prostate, Oncogene, 26, 1885, 10.1038/sj.onc.1209991 · DOI
  69. Leach, 2017, The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome, Prostate, 77, 185, 10.1002/pros.23259 · DOI
  70. Yong, 2007, Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology, J. Biol. Chem., 282, 5026, 10.1074/jbc.M609360200 · DOI · Paper page
  71. Yeh, 2002, Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues, Proc. Natl. Acad. Sci. USA, 99, 13498, 10.1073/pnas.212474399 · DOI · Paper page
  72. Sanchez, 2012, Chaperoning steroidal physiology: Lessons from mouse genetic models of Hsp90 and its cochaperones, Biochim. Biophys. Acta, 1823, 722, 10.1016/j.bbamcr.2011.11.006 · DOI · Paper page
  73. Solassol, 2011, FKBP family proteins as promising new biomarkers for cancer, Curr. Opin. Pharmacol., 11, 320, 10.1016/j.coph.2011.03.012 · DOI
  74. Russo, D., Merolla, F., Mascolo, M., Ilardi, G., Romano, S., Varricchio, S., Napolitano, V., Celetti, A., Postiglione, L., and Di Lorenzo, P.P. (2017). FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?. Int. J. Mol. Sci., 18. · DOI
  75. Bonner, 2017, Diverse structures, functions and uses of FK506 binding proteins, Cell Signal., 38, 97, 10.1016/j.cellsig.2017.06.013 · DOI
  76. Huang, 2015, Silencing of Taxol-Sensitizer Genes in Cancer Cells: Lack of Sensitization Effects, Cancers, 7, 1052, 10.3390/cancers7020824 · DOI
  77. Rotoli, 2016, Expression and localization of the immunophilin FKBP51 in colorectal carcinomas and primary metastases, and alterations following oxaliplatin-based chemotherapy, Oncol. Lett., 12, 1315, 10.3892/ol.2016.4772 · DOI
  78. Rotoli, D., Morales, M., Avila, J., Maeso, M.D.C., Garcia, M.D.P., Mobasheri, A., and Martin-Vasallo, P. (2017). Commitment of Scaffold Proteins in the Onco-Biology of Human Colorectal Cancer and Liver Metastases after Oxaliplatin-Based Chemotherapy. Int. J. Mol. Sci., 18. · DOI
  79. Liu, 2010, Proteomic mining in the dysplastic liver of WHV/c-myc mice--insights and indicators for early hepatocarcinogenesis, FEBS J., 277, 4039, 10.1111/j.1742-4658.2010.07795.x · DOI
  80. Xu, 2016, The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals, EBioMedicine, 12, 55, 10.1016/j.ebiom.2016.07.013 · DOI
  81. Sun, 2017, The non-canonical NF-κB pathway in immunity and inflammation, Nat. Rev. Immunol., 17, 545, 10.1038/nri.2017.52 · DOI · Paper page
  82. Gilmore, 2006, Introduction to NF-κB: Players, pathways, perspectives, Oncogene, 25, 6680, 10.1038/sj.onc.1209954 · DOI · Paper page
  83. Mackenzie, 2006, Microtubules are required for NF-κB nuclear translocation in neuroblastoma IMR-32 cells: Modulation by zinc, J. Neurochem., 99, 402, 10.1111/j.1471-4159.2006.04005.x · DOI
  84. Gojoubori, 2016, Electrolytically generated acid functional water inhibits NF-κB activity by attenuating nuclear-cytoplasmic shuttling of p65 and p50 subunits, J. Recept. Signal Transduct. Res., 36, 248, 10.3109/10799893.2015.1086883 · DOI
  85. Ryo, 2003, Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA, Mol. Cell, 12, 1413, 10.1016/S1097-2765(03)00490-8 · DOI · Paper page
  86. Wulf, 2003, The prolyl isomerase Pin1 in breast development and cancer, Breast Cancer Res., 5, 76, 10.1186/bcr572 · DOI · Paper page
  87. Wulf, 2001, Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1, EMBO J., 20, 3459, 10.1093/emboj/20.13.3459 · DOI · Paper page
  88. Bao, 2004, Prevalent overexpression of prolyl isomerase Pin1 in human cancers, Am. J. Pathol., 164, 1727, 10.1016/S0002-9440(10)63731-5 · DOI · Paper page
  89. Yoshimura, 2003, Negative regulation of cytokine signaling influences inflammation, Curr. Opin. Immunol., 15, 704, 10.1016/j.coi.2003.09.004 · DOI
  90. Romano, 2015, FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma, Nucleic Acids Res., 43, 6983, 10.1093/nar/gkv615 · DOI · Paper page
  91. Romano, 2010, Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells, Cell Death Differ., 17, 145, 10.1038/cdd.2009.115 · DOI
  92. Luo, 2017, USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling, EMBO J., 36, 1434, 10.15252/embj.201695669 · DOI
  93. Wang, 2011, FKBP51 regulation of AKT/protein kinase B phosphorylation, Curr. Opin. Pharmacol., 11, 360, 10.1016/j.coph.2011.03.008 · DOI
  94. Dogan, 2018, Correlation between telomerase and mTOR pathway in cancer stem cells, Gene, 641, 235, 10.1016/j.gene.2017.09.072 · DOI
  95. Koundouros, 2018, Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer, Front. Oncol., 8, 160, 10.3389/fonc.2018.00160 · DOI · Paper page
  96. Hausch, 2013, FKBPs and the Akt/mTOR pathway, Cell Cycle, 12, 2366, 10.4161/cc.25508 · DOI
  97. Baretic, 2014, The structural basis for mTOR function, Semin. Cell Dev. Biol., 36, 91, 10.1016/j.semcdb.2014.09.024 · DOI
  98. Romano, 2011, The emerging role of large immunophilin FK506 binding protein 51 in cancer, Curr. Med. Chem., 18, 5424, 10.2174/092986711798194333 · DOI
  99. Zaytseva, 2012, mTOR inhibitors in cancer therapy, Cancer Lett., 319, 1, 10.1016/j.canlet.2012.01.005 · DOI · Paper page
  100. Liu, 2017, Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells, Oncol. Rep., 38, 271, 10.3892/or.2017.5648 · DOI
  101. Cazzaniga, 2018, Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged >/= 65 years: New lessons for clinical practice from the EVA study, Oncotarget, 9, 31877, 10.18632/oncotarget.25874 · doi:10.18632/oncotarget.25874
  102. Hasskarl, 2018, Everolimus, Recent Results Cancer Res., 211, 101, 10.1007/978-3-319-91442-8_8 · DOI
  103. Gallo, 2011, The 90-kDa heat-shock protein (Hsp90)-binding immunophilin FKBP51 is a mitochondrial protein that translocates to the nucleus to protect cells against oxidative stress, J. Biol. Chem., 286, 30152, 10.1074/jbc.M111.256610 · DOI · Paper page
  104. Akiyama, T., Shiraishi, T., Qin, J., Konno, H., Akiyama, N., Shinzawa, M., Miyauchi, M., Takizawa, N., Yanai, H., and Ohashi, H. (2014). Mitochondria-nucleus shuttling FK506-binding protein 51 interacts with TRAF proteins and facilitates the RIG-I-like receptor-mediated expression of type I IFN. PLOS ONE, 9. · DOI · Paper page
  105. Toneatto, 2013, Dynamic mitochondrial-nuclear redistribution of the immunophilin FKBP51 is regulated by the PKA signaling pathway to control gene expression during adipocyte differentiation, J. Cell Sci., 126, 5357
  106. Eisenstein, 2011, Telomeres: All's well that ends well, Nature, 478, S13, 10.1038/478S13a · DOI
  107. Gomes, 2010, Telomere biology in Metazoa, FEBS Lett., 584, 3741, 10.1016/j.febslet.2010.07.031 · DOI · Paper page
  108. Shore, 2009, Telomere length regulation: Coupling DNA end processing to feedback regulation of telomerase, EMBO J., 28, 2309, 10.1038/emboj.2009.195 · DOI · Paper page
  109. Calado, 2009, Telomere diseases, New Engl. J. Med., 361, 2353, 10.1056/NEJMra0903373 · DOI · Paper page
  110. Masutomi, 2000, Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component, J. Biol. Chem., 275, 22568, 10.1074/jbc.M000622200 · DOI · Paper page
  111. Forsythe, 2001, Stable association of hsp90 and p23, but Not hsp70, with active human telomerase, J. Biol. Chem., 276, 15571, 10.1074/jbc.C100055200 · DOI · Paper page
  112. Holt, 1999, Functional requirement of p23 and Hsp90 in telomerase complexes, Genes Dev., 13, 817, 10.1101/gad.13.7.817 · DOI · Paper page
  113. Yao, 2011, FKBPs in chromatin modification and cancer, Curr. Opin. Pharmacol., 11, 301, 10.1016/j.coph.2011.03.005 · DOI
  114. Leach, D.A., and Buchanan, G. (2017). Stromal Androgen Receptor in Prostate Cancer Development and Progression. Cancers, 9. · DOI
  115. Kim, 2012, Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs, J. Immunol., 188, 4226, 10.4049/jimmunol.1103040 · DOI · Paper page
  116. Li, 2011, The role of FKBP5 in cancer aetiology and chemoresistance, Br. J. Cancer, 104, 19, 10.1038/sj.bjc.6606014 · DOI
  117. Mukaide, 2008, FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma, Cancer Investig., 26, 385, 10.1080/07357900701799228 · DOI
  118. Amiri, 2007, Geldanamycin anisimycins activate Rho and stimulate Rho- and ROCK-dependent actin stress fiber formation, Mol. Cancer Res., 5, 933, 10.1158/1541-7786.MCR-06-0362 · DOI
  119. Houle, 2006, Phosphorylation of focal adhesion kinase (FAK) on Ser732 is induced by rho-dependent kinase and is essential for proline-rich tyrosine kinase-2-mediated phosphorylation of FAK on Tyr407 in response to vascular endothelial growth factor, Mol. Biol. Cell, 17, 3508, 10.1091/mbc.e05-12-1158 · DOI
  120. Takaoka, 2017, FKBP51 regulates cell motility and invasion via RhoA signaling, Cancer Sci., 108, 380, 10.1111/cas.13153 · DOI
  121. Ostrow, 2009, Pharmacologic unmasking of epigenetically silenced genes in breast cancer, Clin. Cancer Res., 15, 1184, 10.1158/1078-0432.CCR-08-1304 · DOI
  122. Pearson, J.D., Mohammed, Z., Bacani, J.T., Lai, R., and Ingham, R.J. (2012). The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein. BMC Cancer, 12. · DOI
  123. Russo, 2017, A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma, Oncotarget, 8, 68291, 10.18632/oncotarget.19309 · DOI · Paper page
  124. Wirsching, 2016, Glioblastoma, Handb. Clin. Neurol., 134, 381, 10.1016/B978-0-12-802997-8.00023-2 · DOI · Paper page
  125. Wang, 2017, Cycloheximide promotes paraptosis induced by inhibition of cyclophilins in glioblastoma multiforme, Cell Death Dis., 8, e2807, 10.1038/cddis.2017.217 · DOI
  126. Ma, 2006, NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with α interferon, Antimicrob. Agents Chemother., 50, 2976, 10.1128/AAC.00310-06 · DOI · Paper page
  127. Duzgun, 2016, Role of mTOR in glioblastoma, Gene, 575, 187, 10.1016/j.gene.2015.08.060 · DOI
  128. Donley, 2014, Identification of RBCK1 as a novel regulator of FKBPL: Implications for tumor growth and response to tamoxifen, Oncogene, 33, 3441, 10.1038/onc.2013.306 · DOI
  129. Nelson, 2015, FKBPL: A marker of good prognosis in breast cancer, Oncotarget, 6, 12209, 10.18632/oncotarget.3528 · DOI
  130. Renoir, 2012, Estradiol receptors in breast cancer cells: Associated co-factors as targets for new therapeutic approaches, Steroids, 77, 1249, 10.1016/j.steroids.2012.07.019 · DOI
  131. Renoir, 2013, Estrogen receptor signaling as a target for novel breast cancer therapeutics, Biochem. Pharmacol., 85, 449, 10.1016/j.bcp.2012.10.018 · DOI · Paper page
  132. Desmetz, 2009, Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women, Clin. Cancer Res., 15, 4733, 10.1158/1078-0432.CCR-08-3307 · DOI
  133. Dhamad, A.E., Zhou, Z., Zhou, J., and Du, Y. (2016). Systematic Proteomic Identification of the Heat Shock Proteins (Hsp) that Interact with Estrogen Receptor α (ERα) and Biochemical Characterization of the ERα-Hsp70 Interaction. PLoS ONE, 11. · DOI
  134. Garifulin, 2015, Application of serex-analysis for identification of human colon cancer antigens, Exp. Oncol., 37, 173, 10.31768/2312-8852.2015.37(3):173-180 · doi:10.31768/2312-8852.2015.37(3):173-180
  135. Duthie, 2007, Proteomics analysis of interleukin (IL)-7-induced signaling effectors shows selective changes in IL-7Rα449F knock-in T cell progenitors, Mol. Cell. Proteom., 6, 1700, 10.1074/mcp.M600468-MCP200 · DOI
  136. Quinta, 2011, Management of cytoskeleton architecture by molecular chaperones and immunophilins, Cell Signal., 23, 1907, 10.1016/j.cellsig.2011.07.023 · DOI
  137. Quinta, 2012, The neuroregenerative mechanism mediated by the Hsp90-binding immunophilin FKBP52 resembles the early steps of neuronal differentiation, Br. J. Pharmacol., 166, 637, 10.1111/j.1476-5381.2011.01783.x · DOI
  138. Ott, 2015, Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway, Glia, 63, 78, 10.1002/glia.22734 · DOI
  139. Lim, 2002, Proteome analysis of hepatocellular carcinoma, Biochem. Biophys. Res. Commun., 291, 1031, 10.1006/bbrc.2002.6547 · doi:10.1006/bbrc.2002.6547
  140. Schulke, J.P., Wochnik, G.M., Lang-Rollin, I., Gassen, N.C., Knapp, R.T., Berning, B., Yassouridis, A., and Rein, T. (2010). Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors. PLoS ONE, 5. · DOI · Paper page
  141. Tranguch, 2006, Progesterone receptor requires a co-chaperone for signalling in uterine biology and implantation, Reprod. Biomed. Online, 13, 651, 10.1016/S1472-6483(10)60655-4 · DOI
  142. Lagadari, 2016, Regulation of NF-κB signalling cascade by immunophilins, Curr. Mol. Pharmacol., 9, 99, 10.2174/1874467208666150519113833 · DOI
  143. Maschi, 2010, Subcellular rearrangement of hsp90-binding immunophilins accompanies neuronal differentiation and neurite outgrowth, J. Neurochem., 115, 716, 10.1111/j.1471-4159.2010.06970.x · DOI · Paper page
  144. Dai, 2004, A novel role for the immunophilin FKBP52 in copper transport, J. Biol. Chem., 279, 27845, 10.1074/jbc.C400118200 · DOI
  145. Nguyen, 2013, Hsp90 chaperones PPARgamma and regulates differentiation and survival of 3T3-L1 adipocytes, Cell Death Differ., 20, 1654, 10.1038/cdd.2013.129 · DOI
  146. Desarzens, S., Liao, W.H., Mammi, C., Caprio, M., and Faresse, N. (2014). Hsp90 blockers inhibit adipocyte differentiation and fat mass accumulation. PLoS ONE, 9. · DOI
  147. Verstraeten, 2011, Reorganization of the nuclear lamina and cytoskeleton in adipogenesis, Histochem. Cell Biol., 135, 251, 10.1007/s00418-011-0792-4 · DOI
  148. Hetzer, 2006, The role of the nuclear envelope in cellular organization, Cell. Mol. Life Sci., 63, 316, 10.1007/s00018-005-5361-3 · DOI
  149. Stuurman, 1997, Identification of a conserved phosphorylation site modulating nuclear lamin polymerization, FEBS Lett., 401, 171, 10.1016/S0014-5793(96)01464-0 · doi:10.1016/s0014-5793(96)01464-0
  150. Stechschulte, 2014, FKBP51 reciprocally regulates GRα and PPARgamma activation via the Akt-p38 pathway, Mol. Endocrinol., 28, 1254, 10.1210/me.2014-1023 · DOI
  151. Stechschulte, 2014, FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARgamma, Mol. Endocrinol., 28, 1265, 10.1210/me.2014-1022 · DOI
  152. O'Leary, J.C., Dharia, S., Blair, L.J., Brady, S., Johnson, A.G., Peters, M., Cheung-Flynn, J., Cox, M.B., de Erausquin, G., and Weeber, E.J. (2011). A new anti-depressive strategy for the elderly: Ablation of FKBP5/FKBP51. PLoS ONE, 6. · DOI · Paper page
  153. Touma, 2011, FK506 binding protein 5 shapes stress responsiveness: Modulation of neuroendocrine reactivity and coping behavior, Biol. Psychiatry, 70, 928, 10.1016/j.biopsych.2011.07.023 · DOI · Paper page
  154. Stechschulte, 2016, FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARgamma Agonist Rosiglitazone, Endocrinology, 157, 3888, 10.1210/en.2015-1996 · DOI · Paper page
  155. Hardwick, 2018, Cell cycle-dependent phosphorylation and regulation of cellular differentiation, Biochem. Soc. Trans., 46, 1083, 10.1042/BST20180276 · DOI
  156. Scharf, S.H., Liebl, C., Binder, E.B., Schmidt, M.V., and Muller, M.B. (2011). Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS ONE, 6. · DOI · Paper page
  157. Fries, 2015, The FKBP51-Glucocorticoid Receptor Balance in Stress-Related Mental Disorders, Curr. Mol. Pharmacol., 9, 126, 10.2174/1874467208666150519114435 · DOI
  158. Paquette, A.G., Lester, B.M., Koestler, D.C., Lesseur, C., Armstrong, D.A., and Marsit, C.J. (2014). Placental FKBP5 genetic and epigenetic variation is associated with infant neurobehavioral outcomes in the RICHS cohort. PLoS ONE, 9. · DOI · Paper page
  159. Rein, 2018, Hsp90 and FKBP51: Complex regulators of psychiatric diseases, Philos. Trans. R. Soc. Lond. Ser. Biol. Sci., 373, 20160532, 10.1098/rstb.2016.0532 · DOI · Paper page
  160. Ising, 2008, Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls, Eur. J. Neurosci., 28, 389, 10.1111/j.1460-9568.2008.06332.x · DOI · Paper page
  161. Mahon, 2013, Genetic association of FKBP5 and CRHR1 with cortisol response to acute psychosocial stress in healthy adults, Psychopharmacology, 227, 231, 10.1007/s00213-012-2956-x · DOI · Paper page
  162. Shibuya, 2010, Association study between a functional polymorphism of FK506-binding protein 51 (FKBP5) gene and personality traits in healthy subjects, Neurosci. Lett., 485, 194, 10.1016/j.neulet.2010.09.010 · DOI
  163. Fani, 2014, FKBP5 genotype and structural integrity of the posterior cingulum, Neuropsychopharmacology, 39, 1206, 10.1038/npp.2013.322 · DOI
  164. Fani, 2013, FKBP5 and attention bias for threat: Associations with hippocampal function and shape, JAMA Psychiatry, 70, 392, 10.1001/2013.jamapsychiatry.210 · DOI · Paper page
  165. Fujii, 2014, Association between the common functional FKBP5 variant (rs1360780) and brain structure in a non-clinical population, J. Psychiatr. Res., 58, 96, 10.1016/j.jpsychires.2014.07.009 · DOI
  166. Szabo, 2013, Association among clinical response, hippocampal volume, and FKBP5 gene expression in individuals with posttraumatic stress disorder receiving cognitive behavioral therapy, Biol. Psychiatry, 74, 793, 10.1016/j.biopsych.2013.05.017 · DOI
  167. Pohlmann, 2018, Pharmacological Modulation of the Psychiatric Risk Factor FKBP51 Alters Efficiency of Common Antidepressant Drugs, Front. Behav. Neurosci., 12, 262, 10.3389/fnbeh.2018.00262 · DOI · Paper page
  168. Gassen, 2015, Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine, Sci. Signal., 8, ra119, 10.1126/scisignal.aac7695 · DOI · Paper page

Cited by

Metadata

Authors
Zgajnar, N., De Leo, S., Lotufo, C., Erlejman, A., Piwien-Pilipuk, G., & Galigniana, M.
Venue
Biomolecules
Publisher
MDPI AG
Published
2019-02-01
Volume
9
Issue
2
Pages
52
ISSN
2218-273X (ISSN-L)
OpenAlex
W2912308905
Cited by
94
References
60
FWCI
3.72
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.